2018
DOI: 10.1136/esmoopen-2018-eacr25.324
|View full text |Cite
|
Sign up to set email alerts
|

PO-293 Withaferin-A: a candidate anti-tumour natural compound for non-small cell lung cancer and stem cells

Abstract: ConclusionIn conclusion, exerts an important antitumor effect by inhibiting c-Src and up-regulating PTEN with the subsequent reduction in FAK phosphorylation required to establish appropriate focal adhesions for migration, proliferation and survival. This inhibition is mediated by the recruitment of the c-Src intrinsic inhibitors, PTEN and Csk. All together, these results reinforce the relevance of this sequence of Cx43 that interacts with c-Src for the development of new therapies against glioblastoma. PO-29… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles